TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
Clinical trial NCT05496569 · TERMINATED
Trial details
- NCT number
- NCT05496569
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-08
- Primary completion
- 2024-06-15
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.